Medidata Wins Top Honor for its Clinical Data Studio by Enterprise Asia and Top Company in Clinical Research-Based Development by BioSpectrum Asia
- Medidata won the Enterprise Asia International Innovation Award for Medidata Clinical Data Studio. This is the fifth consecutive year that Enterprise Asia has recognized Medidata for its contribution in the life sciences space
- Medidata was named the Top Company in Clinical Research-Based Development at the 2024 BioSpectrum Asia Excellence Awards for the first time
Singapore – 14 Jan., 2025 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has received the Enterprise Asia International Innovation Award for the fifth consecutive year and the BioSpectrum Asia Excellence Award for the Top Company in Clinical Research-Based Development. Medidata won the International Innovation Award in the Service and Solution category for Clinical Data Studio.
"We’re honored to receive these prestigious awards as each highlight Medidata’s unwavering commitment to transforming clinical research and patient experience through innovation,” said Edwin Ng, senior vice president and general manager, Asia-Pacific, Medidata. “Clinical Data Studio exemplifies how we are harnessing technology to address the complexities of modern trials, delivering faster, patient-centric research, and driving meaningful impact on global health.”
The International Innovation Award, given by Enterprise Asia, acknowledges organizations that demonstrate outstanding innovation in delivering services or solutions that significantly enhance customer value, efficiency, or industry impact. Medidata Clinical Data Studio was recognized for its innovative AI-powered, no/low-code platform that streamlines complex clinical trials by integrating and analyzing multi-source data, delivering valuable patient insights, and enhancing efficiency.
The 2024 BioSpectrum Asia Excellence Awards honor leading biotech and health sciences companies for their contributions to the field. Medidata received the Top Company in Clinical Research-Based Development award as part of the Editor’s Choice recognition, highlighting its performance, achievements, and impact in advancing healthcare innovation in Asia. The award underscores Medidata's role in powering smarter treatments and healthier people.
To learn more about these accolades, please visit here.
About Medidata
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 350,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: www.3ds.com